Ho Wah Genting Berhad Gestione

Gestione criteri di controllo 2/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEO	n/a
Mandato del CEO	no data
Proprietà del CEO	n/a
Durata media del management	12.1yrs
Durata media del Consiglio di amministrazione	3.3yrs

Aggiornamenti recenti sulla gestione

Recent updates

Is Ho Wah Genting Berhad (KLSE:HWGB) A Risky Investment?

Jul 25

Ho Wah Genting Berhad's (KLSE:HWGB) Shares Bounce 26% But Its Business Still Trails The Industry

Jun 18

These 4 Measures Indicate That Ho Wah Genting Berhad (KLSE:HWGB) Is Using Debt Reasonably Well

May 22

Ho Wah Genting Berhad (KLSE:HWGB) Has A Somewhat Strained Balance Sheet

Dec 06

Returns Are Gaining Momentum At Ho Wah Genting Berhad (KLSE:HWGB)

Oct 05

Here's Why Ho Wah Genting Berhad (KLSE:HWGB) Can Afford Some Debt

Jul 08

AMMINISTRATORE DELEGATO

Ho Wah Genting Berhad non ha un CEO, o non abbiamo dati su di loro.

Gruppo dirigente

Nome	Posizione	Mandato	Compensazione	Proprietà
Ooi Lim	Group Executive Chairman	3.3yrs	RM 613.00k	0.17% MYR 75.6k
Wee Lim	Executive Director	14.4yrs	RM 288.00k	0.12% MYR 55.0k
Hui Lim	Founder	13.4yrs	Nessun dato	0.091% MYR 41.3k
Yew Lam	Chief Financial Officer	3.6yrs	Nessun dato	Nessun dato
Doh Ling	Head of Executive Chairman Department	3.3yrs	Nessun dato	Nessun dato
Tiew Teo	President Director of PT. Ho Wah Genting Indonesia	no data	Nessun dato	2.17% MYR 983.0k
Kim Hong	Head of Secretarial Department & Company Secretary	12.1yrs	Nessun dato	Nessun dato

12.1yrs

Durata media

52yo

Età media

Gestione esperta: Il team dirigenziale di HWGB è esperto e expertise (durata media dell'incarico 12.1 anni).

Membri del Consiglio di amministrazione

Nome	Posizione	Mandato	Compensazione	Proprietà
Ooi Lim	Group Executive Chairman	3.3yrs	RM 613.00k	0.17% MYR 75.6k
Wee Lim	Executive Director	14.4yrs	RM 288.00k	0.12% MYR 55.0k
Tiew Teo	President Director of PT. Ho Wah Genting Indonesia	no data	Nessun dato	2.17% MYR 983.0k
Khi Yeoh	Independent Non-Executive Director	6.4yrs	RM 64.00k	Nessun dato
Khalid Bin Ahmad Husni	Independent & Non Executive Director	2.4yrs	RM 64.00k	Nessun dato
Ean Lim	Independent Non-Executive Director	less than a year	Nessun dato	Nessun dato

3.3yrs

Durata media

43.5yo

Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di HWGB sono considerati esperti (durata media dell'incarico 3.3 anni).

Ho Wah Genting Berhad Gestione

Gestione criteri di controllo 2/4

Informazioni chiave

Aggiornamenti recenti sulla gestione

Ho Wah Genting Berhad Appoints Madam Lim Ean Chin as Independent and Non Executive Director

Ho Wah Genting Berhad Announces the Resignation of Elaine Tan Ai Lin as Independent and Non Executive Chairman of Nomination and Remuneration Committee

Ho Wah Genting Berhad, Annual General Meeting, Sep 28, 2022

Ho Wah Genting Berhad Announces Appointment of Khalid Bin Ahmad Husni as Independent and Non Executive Member of Nomination and Remuneration Committee

Ho Wah Genting Berhad Appoints Kay Wong-Alafriz, as Advisor

Ho Wah Genting Berhad Appoints Law Phooi Wong as Advisor to the Board

Recent updates

New major risk - Market cap size

Second quarter 2024 earnings released: EPS: RM0.006 (vs RM0.036 loss in 2Q 2023)

Is Ho Wah Genting Berhad (KLSE:HWGB) A Risky Investment?

Ho Wah Genting Berhad Appoints Madam Lim Ean Chin as Independent and Non Executive Director

Ho Wah Genting Berhad's (KLSE:HWGB) Shares Bounce 26% But Its Business Still Trails The Industry

Ho Wah Genting Berhad (KLSE:HWGB) Is Experiencing Growth In Returns On Capital

First quarter 2024 earnings released: RM0.001 loss per share (vs RM0.036 loss in 1Q 2023)

Ho Wah Genting Berhad Announces the Resignation of Elaine Tan Ai Lin as Independent and Non Executive Chairman of Nomination and Remuneration Committee

Full year 2023 earnings released: EPS: RM0.007 (vs RM0.01 loss in FY 2022)

New major risk - Market cap size

New minor risk - Financial data availability

Ho Wah Genting Berhad (KLSE:HWGB) Is Experiencing Growth In Returns On Capital

New major risk - Market cap size

New minor risk - Shareholder dilution

Many Still Looking Away From Ho Wah Genting Berhad (KLSE:HWGB)

These 4 Measures Indicate That Ho Wah Genting Berhad (KLSE:HWGB) Is Using Debt Reasonably Well

Full year 2022 earnings released: RM0.003 loss per share (vs RM0.009 loss in FY 2021)

Second quarter 2023 earnings released: EPS: RM0.002 (vs RM0.007 loss in 2Q 2022)

Ho Wah Genting Berhad (KLSE:HWGB) Has A Somewhat Strained Balance Sheet

Returns Are Gaining Momentum At Ho Wah Genting Berhad (KLSE:HWGB)

Full year 2022 earnings released: RM0.009 loss per share (vs RM0.046 loss in FY 2021)

Ho Wah Genting Berhad, Annual General Meeting, Sep 28, 2022

Ho Wah Genting Berhad has completed a Follow-on Equity Offering in the amount of MYR 2.939792 million.

Here's Why Ho Wah Genting Berhad (KLSE:HWGB) Can Afford Some Debt

Ho Wah Genting Berhad Announces Appointment of Khalid Bin Ahmad Husni as Independent and Non Executive Member of Nomination and Remuneration Committee

Full year 2022 earnings released: RM0.009 loss per share (vs RM0.046 loss in FY 2021)

Ho Wah Genting Berhad Update on Phase 4 United States Food and Drug Administration Clinical Trial of Sars-Cov-2 Vaccine Study

Ho Wah Genting Berhad Appoints Kay Wong-Alafriz, as Advisor

New 90-day low: RM0.55

Full year 2020 earnings released: RM0.044 loss per share (vs RM0.019 loss in FY 2019)

Ho Wah Genting Berhad Appoints Law Phooi Wong as Advisor to the Board

Ho Wah Genting Berhad Announces Update on Phase 4 Clinical Trial of Sars-Cov-2 Vaccine Study

Ho Wah Genting Berhad Receives Product Registration Approval for Astramern Astra H Capsule from NPRA for A Period Commencing 14 January 2021 to 14 January 2026

Ho Wah Genting Berhad Enters into Memorandum of Understanding with Chongqing ISIA Bio-Technology Co., Ltd (ISIA) to Manufacture and Produce in Vitro Diagnostic Products

New 90-day low: RM0.59

Ho Wah Genting Berhad Provides Update on Phase 4 Clinical Trial of Sars-Cov-2 Vaccine Study

Ho Wah Genting Berhad Announces Benjamin Leong Wye Hoong as Independent and Non Executive Director

New 90-day high: RM0.89

Ho Wah Genting Berhad Provides Update on the Joint Venture Project with E-Mo Biology Inc

Third quarter 2020 earnings released: RM0.002 loss per share

Ho Wah Genting Berhad Enters into Memorandum of Understanding with GNOSIS LABORATORIES (M) SDN BHD

Ho Wah Genting Berhad Provides Update on the Joint Venture Project with E-Mo Biology Inc

Ho Wah Genting Berhad Announces Appointment as the Authorized Sale Agent/ Distributor for the Covid-19 related products from Wuhan Easy Diagnosis Biomedicine Co.,Ltd

Ho Wah Genting Berhad Announces Resignation of Mr. Bernard Lim Soon Chiang as Independent and Non Executive Member of Remuneration Committee

Ho Wah Genting Berhad Announces Redesignation of Mr. Kenny Yeoh Khi Khen from Independent and Non Executive Member of Risk Committee to Chairman of Risk Committee

First half earnings released

Dato Lim Ooi Hong, Lim Wee Kiat and Datuk Teo Tiew, Executive Directors of Ho Wah Genting Berhad completed the acquisition of remaining 70.24% stake in Ho Wah Genting Berhad (KLSE:HWGB).

New 90-day high - RM0.60

AMMINISTRATORE DELEGATO

Gruppo dirigente

Durata media

Età media

Membri del Consiglio di amministrazione

Durata media

Età media